BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Ana Paula Pagano, Juliana Maria Faccioli Sicchieri, Clara Romanholi Passos, Camila Sanches Manca, Isabela Laurencio Schiavoni, Andreza Correa Teixeira, Ana de Lourdes Candolo Martinelli, Paula Garcia Chiarello. Hand grip strength and adductor pollicis muscle thickness in patients on palliative care for hepatocellular carcinomaClinical Nutrition Experimental 2018; 22: 30 doi: 10.1016/j.yclnex.2018.06.003
2
Khaled Farid, Hatem ElAlfy, Salwa M. Abo El-Khair, Hoda Elgamal, Tarek Besheer, Ali Elmokadem, Walaa Shabana, Sally Abed, Mohamed Elegezy, Ahmed Abd El-khalek, Ahmed El-Morsy, Amr Negm, Ayman Z. Elsamanoudy, Basem El deek, Talal Amer, Mahmoud El-Bendary. Prognostic value of vascular endothelial growth factor in both conventional and drug eluting beads transarterial chemoembolization for treatment of unresectable hepatocellular carcinoma in HCV patients.Expert Review of Gastroenterology & Hepatology 2020;  doi: 10.1080/17474124.2020.1823215
3
Xinmin Guo, Shunhua Guo, Liwen Pan, Li Ruan, Yingshi Gu, Jichuang Lai. Anti-microRNA-21/221 and microRNA-199a transfected by ultrasound microbubbles induces the apoptosis of human hepatoma HepG2 cellsOncology Letters 2017; 13(5): 3669 doi: 10.3892/ol.2017.5910
4
Hojung Jung, Byung Ik Kim, Yong Kyun Cho, Woo Kyu Jeon, Hong Joo Kim, Hyun Pyo Hong. Complete cure of advanced hepatocellular carcinoma with right adrenal gland metastasis and portal vein thrombosis by multiple applications of an interdisciplinary therapy: case report with 8-year follow upClinical and Molecular Hepatology 2018; 24(4): 424 doi: 10.3350/cmh.2017.0032
5
Zeng Wang-Yuan, Zeng Jiang-Zheng, Yan-Da Lu, Xin-Bao Hao, Tao Hong, Fen Huang, Jun-Hua Lei, Zhi-Hui He, Mei-zhu Huang. Clinical efficacy of metronomic chemotherapy after cool-tip radiofrequency ablation in the treatment of hepatocellular carcinomaInternational Journal of Hyperthermia 2016; 32(2): 193 doi: 10.3109/02656736.2015.1099168
6
Mamdouh M Ali, Ibrahim H Borai, Hala M Ghanem, Abeer H Abdel-Halim, Fatma M Mousa. The prophylactic and therapeutic effects of Momordica charantia methanol extract through controlling different hallmarks of the hepatocarcinogenesisBiomedicine & Pharmacotherapy 2018; 98: 491 doi: 10.1016/j.biopha.2017.12.096
7
Ratna Kumari, Manoj Kumar Sahu, Anindita Tripathy, Kanishka Uthansingh, Manas Behera. Hepatocellular carcinoma treatment: hurdles, advances and prospectsHepatic Oncology 2018; 5(2): HEP08 doi: 10.2217/hep-2018-0002
8
Olivier Sutter, Joyce Calvo, Gisèle N’Kontchou, Jean-Charles Nault, Raffik Ourabia, Pierre Nahon, Nathalie Ganne-Carrié, Valérie Bourcier, Nora Zentar, Fatna Bouhafs, Nicolas Sellier, Abou Diallo, Olivier Seror. Safety and Efficacy of Irreversible Electroporation for the Treatment of Hepatocellular Carcinoma Not Amenable to Thermal Ablation Techniques: A Retrospective Single-Center Case SeriesRadiology 2017; 284(3): 877 doi: 10.1148/radiol.2017161413
9
Xue-Fen Lei, Yang Ke, Tian-Hao Bao, Hao-Ran Tang, Xue-Song Wu, Zhi-Tian Shi, Jie Lin, Zhi-Xian Zhang, Hou Gu, Lin Wang. Effect and safety of sorafenib in patients with intermediate hepatocellular carcinoma who received transarterial chemoembolization: A retrospective comparative studyWorld Journal of Clinical Cases 2018; 6(5): 74-83 doi: 10.12998/wjcc.v6.i5.74
10
Maria Pipa-Muñiz, Lluis Castells, Sonia Pascual, Javier Fernández-Castroagudín, Iratxe Díez-Miranda, Javier Irurzun, Roberto Díaz-Beveridge, María Senosiaín, Juan Arenas, Manuel de la Mata, Juan Turnes, María Isabel Monge-Romero, Daniel Pérez-Enguix, Javier Bustamante-Schneider, Nora Otegui, Esther Molina-Pérez, José Eduardo Rodríguez-Menéndez, Maria Varela. The ART-SCORE is not an effective tool for optimizing patient selection for DEB-TACE retreatment. A multicentre Spanish studyGastroenterología y Hepatología (English Edition) 2017; 40(8): 515 doi: 10.1016/j.gastre.2017.05.007
11
Chengxu Ruan, Lijuan You, Yingdong Qiu, Xiao Cui, Defeng Wu. Tubeimoside I induces autophagy in HepG2 cells by activating the AMP‑activated protein kinase signaling pathwayOncology Letters 2020; 20(1): 623 doi: 10.3892/ol.2020.11604
12
Qing-Liang Wang, Xiao-Jie Li, Zhi-Cheng Yao, Peng Zhang, Shi-Lei Xu, He Huang, Kun-Peng Hu. Sorafenib-induced acute-on-chronic liver failure in a patient with hepatocellular carcinoma after transarterial chemoembolization and radiofrequency ablation: A case reportMolecular and Clinical Oncology 2017; 7(4): 693 doi: 10.3892/mco.2017.1363
13
Li‐Hua Luo, Min Jin, Lan‐Qing Wang, Guo‐Jie Xu, Zhen‐Yu Lin, Dan‐Dan Yu, Sheng‐Li Yang, Rui‐Zhi Ran, Gang Wu, Tao Zhang. Long noncoding RNA TCL6 binds to miR‐106a‐5p to regulate hepatocellular carcinoma cells through PI3K/AKT signaling pathwayJournal of Cellular Physiology 2020; 235(9): 6154 doi: 10.1002/jcp.29544
14
Yanfeng Shen, Feng Xi, Haibin Li, Yin Luo, Cheng Chen, Lei Wang. Telomerase reverse transcriptase suppression inhibits cell proliferation and promotes cell apoptosis in hepatocellular cancerIUBMB Life 2018; 70(7): 642 doi: 10.1002/iub.1758
15
Nanbao Zhong, Guangming Lv, Zhonghua Chen. High Dose-Volume SBRT Following TACE Improves Clinical Outcomes of Patients with Unresectable Hepatocellular CarcinomaJournal of Cancer Therapy 2016; 7(02): 152 doi: 10.4236/jct.2016.72016
16
Mahmoud A. Dawoud, Rania E. Mohamed, Mohamed S. El Waraki, Ahmed M. Gabr. Single-session combined radiofrequency ablation and transarterial chemoembolization in the treatment of hepatocellular carcinomaThe Egyptian Journal of Radiology and Nuclear Medicine 2017; 48(4): 935 doi: 10.1016/j.ejrnm.2017.06.005
17
Rodolfo Sacco, Michela Antonucci, Giampaolo Bresci, Ambra Corti, Luca Giacomelli, Valeria Mismas, Maurizio Rainieri, Antonio Romano, Roberto Eggenhoffner, Emanuele Tumino, Giuseppe Cabibbo. Curative therapies for hepatocellular carcinoma: an update and perspectivesExpert Review of Anticancer Therapy 2016; 16(2): 169 doi: 10.1586/14737140.2016.1123625
18
P. Venkat, S.E. Hoffe, J.M. Frakes. Handbook of Supportive and Palliative Radiation Oncology2017; : 231 doi: 10.1016/B978-0-12-803523-8.00015-0
19
Brian I. Carr, Srikanth Nagalla, Ravit Geva. Hepatocellular Carcinoma2016; : 489 doi: 10.1007/978-3-319-34214-6_33
20
Christina A. Arnold, Maryam K. Pezhouh, Dora Lam-Himlin, Meredith E. Pittman, Christopher VandenBussche, Lysandra Voltaggio. 90Y-TheraSpheresThe American Journal of Surgical Pathology 2019; 43(5): 688 doi: 10.1097/PAS.0000000000001223
21
Xinhua Chen, Zhigang Ren, Shengyong Yin, Yuning Xu, Danjing Guo, Haiyang Xie, Lin Zhou, Liming Wu, Jianwen Jiang, Hongchun Li, Junhui Sun, Shusen Zheng. The local liver ablation with pulsed electric field stimulate systemic immune reaction against hepatocellular carcinoma (HCC) with time-dependent cytokine profileCytokine 2017; 93: 44 doi: 10.1016/j.cyto.2017.05.003
22
Maria Pipa-Muñiz, Lluis Castells, Sonia Pascual, Javier Fernández-Castroagudín, Iratxe Díez-Miranda, Javier Irurzun, Roberto Díaz-Beveridge, María Senosiaín, Juan Arenas, Manuel de la Mata, Juan Turnes, María Isabel Monge-Romero, Daniel Pérez-Enguix, Javier Bustamante-Schneider, Nora Otegui, Esther Molina-Pérez, José Eduardo Rodríguez-Menéndez, Maria Varela. The ART-SCORE is not an effective tool for optimizing patient selection for DEB-TACE retreatment. A multicentre Spanish studyGastroenterología y Hepatología 2017; 40(8): 515 doi: 10.1016/j.gastrohep.2017.05.009
23
Julian Biau, Flavien Devun, Pierre Verrelle, Marie Dutreix. Dbait : un concept innovant pour inhiber la réparation de l’ADN et contribuer aux traitements des cancersBulletin du Cancer 2016; 103(3): 227 doi: 10.1016/j.bulcan.2016.01.007
24
Rania E. Mohamed, Mohamed A. Amin, Hazem M. Omar. Apparent diffusion coefficient and dynamic contrast-enhanced MRI as reliable biomarkers for evaluating response to locoregional therapy in hepatocellular carcinoma patientsThe Egyptian Journal of Radiology and Nuclear Medicine 2018; 49(4): 914 doi: 10.1016/j.ejrnm.2018.07.012
25
Hamed Hemati, Jagdeep Kaur, R.C. Sobti, Nirupma Trehanpati. Inhibition of NOTCH signaling pathway chemosensitizes HCC CD133+ cells to vincristine and 5-fluorouracil through upregulation of BBC3Biochemical and Biophysical Research Communications 2020; 525(4): 941 doi: 10.1016/j.bbrc.2020.03.009
26
Lu Fan, Huayun Zhu, Weiwei Tao, Li Liu, Xin Shan, Ming Zhao, Dongdong Sun. Euphorbia factor L2 inhibits TGF-β-induced cell growth and migration of hepatocellular carcinoma through AKT/STAT3Phytomedicine 2019; 62: 152931 doi: 10.1016/j.phymed.2019.152931
27
Quality of Life and Work Ability among Healthcare Personnel with Chronic Viral Hepatitis. Evaluation of the Inpatient Rehabilitation Program of the Wartenberg ClinicInternational Journal of Environmental Research and Public Health 2019; 16(20): 3874 doi: 10.3390/ijerph16203874
28
Meiwan Chen, Xingzhi Zhou, Ruie Chen, Junlin Wang, Richard D. Ye, Yitao Wang, Chuanbin Wu, Ram I. Mahato. Nano-carriers for delivery and targeting of active ingredients of Chinese medicine for hepatocellular carcinoma therapyMaterials Today 2019; 25: 66 doi: 10.1016/j.mattod.2018.10.040
29
Charing Ching-Ning Chong, Grace Lai-Hung Wong. Treatments of Hepatocellular Carcinoma Patients with Hepatitis B Virus Infection: Treat HBV-related HCCAIMS Medical Science 2016; 3(1): 162 doi: 10.3934/medsci.2016.1.162
30
Weizhong Wu, Sanguang Liu, Yunfei Liang, Zegao Zhou, Xueqing Liu. MiR-7 inhibits progression of hepatocarcinoma by targeting KLF-4 and promises a novel diagnostic biomarkerCancer Cell International 2017; 17(1) doi: 10.1186/s12935-017-0386-x
31
Xiaoran Zhang, Jinxiu Li, Meixing Yan. Targeted hepatocellular carcinoma therapy: transferrin modified, self-assembled polymeric nanomedicine for co-delivery of cisplatin and doxorubicinDrug Development and Industrial Pharmacy 2016; 42(10): 1590 doi: 10.3109/03639045.2016.1160103
32
Doris Schneller, Peter Angel. Hepatocellular Carcinoma2019; : 1 doi: 10.15586/hepatocellularcarcinoma.2019.ch1
33
Eric A. Wang, Jeff P. Stein, Ross J. Bellavia, Scott R. Broadwell. Treatment options for unresectable HCC with a focus on SIRT with Yttrium-90 resin microspheresInternational Journal of Clinical Practice 2017; 71(11): e12972 doi: 10.1111/ijcp.12972
34
JING LI, OU LI, MUJIE KAN, MING ZHANG, DAN SHAO, YUE PAN, HUILIN ZHENG, XUEWEN ZHANG, LI CHEN, SONGYAN LIU. Berberine induces apoptosis by suppressing the arachidonic acid metabolic pathway in hepatocellular carcinomaMolecular Medicine Reports 2015; 12(3): 4572 doi: 10.3892/mmr.2015.3926
35
John Chun-Hao Chen, Hui-Yen Chuang, Fei-Ting Hsu, Yi-Chen Chen, Yi-Chun Chien, Jeng-Jong Hwang. Sorafenib pretreatment enhances radiotherapy through targeting MEK/ERK/NF-κB pathway in human hepatocellular carcinoma-bearing mouse modelOncotarget 2016; 7(51): 85450 doi: 10.18632/oncotarget.13398
36
Yang Li, Dan-Yun Ruan, Chang-Chang Jia, Hui Zhao, Guo-Ying Wang, Yang Yang, Nan Jiang. Surgical resection versus liver transplantation for hepatocellular carcinoma within the Hangzhou criteria: a preoperative nomogram-guided treatment strategyHepatobiliary & Pancreatic Diseases International 2017; 16(5): 480 doi: 10.1016/S1499-3872(17)60052-3
37
A Lei Feng, Jian Kang Zhu, Yupeng Yang, Ya Dong Wang, Feng Yue Liu, Min Zhu, Chong Zhong Liu. Repeated postoperative adjuvant TACE after curative hepatectomy improves outcomes of patients with HCCMinimally Invasive Therapy & Allied Technologies 2019; : 1 doi: 10.1080/13645706.2019.1707689
38
Mattia Garancini, Enrico Pinotti, Stefano Nespoli, Fabrizio Romano, Luca Gianotti, Vittorio Giardini. Hepatic resection beyond barcelona clinic liver cancer indication: When and howWorld Journal of Hepatology 2016; 8(11): 513-519 doi: 10.4254/wjh.v8.i11.513
39
Hla-Hla Thein, Yao Qiao, Ahmad Zaheen, Nathaniel Jembere, Gonzalo Sapisochin, Kelvin K. W. Chan, Eric M. Yoshida, Craig C. Earle, Sheng-Nan Lu. Cost-effectiveness analysis of treatment with non-curative or palliative intent for hepatocellular carcinoma in the real-world settingPLOS ONE 2017; 12(10): e0185198 doi: 10.1371/journal.pone.0185198
40
Christoph Eilenberger, Mario Rothbauer, Eva-Kathrin Ehmoser, Peter Ertl, Seta Küpcü. Effect of Spheroidal Age on Sorafenib Diffusivity and Toxicity in a 3D HepG2 Spheroid ModelScientific Reports 2019; 9(1) doi: 10.1038/s41598-019-41273-3
41
Liping Qu, Huiqing Zhang, Yanlong Yang, Geliang Yang, Hailiang Xin, Changquan Ling. Corosolic acid analogue, a natural triterpenoid saponin, induces apoptosis on human hepatocarcinoma cells through mitochondrial pathwayin vitroPharmaceutical Biology 2016; 54(8): 1445 doi: 10.3109/13880209.2015.1104699
42
Nirmitha I. Herath, Flavien Devun, Aurélie Herbette, Marie-Christine Lienafa, Philippe Chouteau, Jian-Sheng Sun, Marie Dutreix, Alban Denys. Potentiation of doxorubicin efficacy in hepatocellular carcinoma by the DNA repair inhibitor DT01 in preclinical modelsEuropean Radiology 2017; 27(10): 4435 doi: 10.1007/s00330-017-4792-1
43
Zhendong Gao, Gang Du, Yuguang Pang, Zhihao Fu, Chongzhong Liu, Yi Liu, Binghai Zhou, Du Kong, Binyao Shi, Zhengcheng Jiang, Bin Jin. Adjuvant transarterial chemoembolization after radical resection contributed to the outcomes of hepatocellular carcinoma patients with high-risk factorsMedicine 2017; 96(33): e7426 doi: 10.1097/MD.0000000000007426
44
Leonardo Lorente, Sergio Rodriguez, Pablo Sanz, Pedro Abreu-González, Dácil Díaz, Antonia Moreno, Elisa Borja, María Martín, Alejandro Jiménez, Manuel Barrera. Association between Pre-Transplant Serum Malondialdehyde Levels and Survival One Year after Liver Transplantation for Hepatocellular CarcinomaInternational Journal of Molecular Sciences 2016; 17(4): 500 doi: 10.3390/ijms17040500
45
J. Arend, K. Schütte, T. Däberitz, T. Bretschneider, F. Benedix, A. Udelnow, St. Wolff, C. J. Bruns. Lebertransplantation bei Malignomen und VorläufererkrankungenDer Onkologe 2016; 22(7): 451 doi: 10.1007/s00761-016-0052-2
46
Baxter Hepburn Kachingwe, Yow-Shieng Uang, Tsurng-Juhn Huang, Li-Hsuan Wang, Shwu-Jiuan Lin. Development and validation of an LC–MS/MS method for quantification of NC-8 in rat plasma and its application to pharmacokinetic studiesJournal of Food and Drug Analysis 2018; 26(1): 401 doi: 10.1016/j.jfda.2017.09.003
47
Jichao Chen, Tianyu Wang, Shengtao Xu, Aijun Lin, Hequan Yao, Weijia Xie, Zheying Zhu, Jinyi Xu. Design, synthesis and biological evaluation of novel nitric oxide-donating protoberberine derivatives as antitumor agentsEuropean Journal of Medicinal Chemistry 2017; 132: 173 doi: 10.1016/j.ejmech.2017.03.027
48
Leonardo Lorente. New prognostic biomarkers of mortality in patients undergoing liver transplantation for hepatocellular carcinomaWorld Journal of Gastroenterology 2018; 24(37): 4230-4242 doi: 10.3748/wjg.v24.i37.4230
49
Nuozhou Wang, Shanshan Wang, Ming-Yue Li, Bao-guang Hu, Li-ping Liu, Sheng-li Yang, Shucai Yang, Zhongqin Gong, Paul B. S. Lai, George G. Chen. Cancer stem cells in hepatocellular carcinoma: an overview and promising therapeutic strategiesTherapeutic Advances in Medical Oncology 2018; 10: 175883591881628 doi: 10.1177/1758835918816287
50
Claire Faltermeier, Ronald Busuttil, Ali Zarrinpar. A Surgical Perspective on Targeted Therapy of Hepatocellular CarcinomaDiseases 2015; 3(4): 221 doi: 10.3390/diseases3040221
51
Mihaela Ignat, Cherif Youssef Akladios, Véronique Lindner, Konstantin Khetchoumian, Marius Teletin, Didier Muttter, Pierre Marc Aprahamian, Jacques Marescaux. Development of a methodology for in vivo follow-up of hepatocellular carcinoma in hepatocyte specific Trim24-null mice treated with myo-inositol trispyrophosphateJournal of Experimental & Clinical Cancer Research 2016; 35(1) doi: 10.1186/s13046-016-0434-8
52
Ines Barone, Cinzia Giordano, Daniela Bonofiglio, Sebastiano Andò, Stefania Catalano. Phosphodiesterase type 5 and cancers: progress and challengesOncotarget 2017; 8(58): 99179 doi: 10.18632/oncotarget.21837